ATF6 is essential for human cone photoreceptor development

Heike Kroeger, Julia M. D. Grandjean, Wei‐Chieh Chiang, Daphne S. Bindels, Rebecca Mastey, Jennifer Okáľová, Amanda Nguyen, Evan T. Powers, Jeffery W. Kelly, Neil Grimsey,

Proceedings of the National Academy of Sciences · 2021 · 53 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

Significance Inactivating genetic variants in the Unfolded Protein Response (UPR) regulator Activating Transcription Factor 6 (ATF6) result in loss of color vision, which is linked to dysfunctional cone photoreceptors and the development of achromatopsia. The pathomechanims involving the lack of functional ATF6 remain unknown; retinal organoids from patient induced pluripotent stem cells and ATF6 null hESCs were generated to elucidate this question. Data from this study identified an unexpected UPR-independent role for ATF6 signaling during cone photoreceptor differentiation in human retinal development, identifying a pathogenic mechanism underlying ATF6-associated achromatopsia. It is believed that pharmacologic targeting of ATF6 may present a viable treatment option for color blinding diseases at early stages of retinal development.

References

33